363 related articles for article (PubMed ID: 9546780)
1. COX-2 inhibitors for colorectal cancer.
Elder DJ; Paraskeva C
Nat Med; 1998 Apr; 4(4):392-3. PubMed ID: 9546780
[No Abstract] [Full Text] [Related]
2. Cyclooxygenase-2 as a target for prevention of colorectal cancer.
Bertagnolli MM
Curr Oncol Rep; 1999; 1(2):173-8. PubMed ID: 11122816
[TBL] [Abstract][Full Text] [Related]
3. COX-2 in large bowel cancer: a one-sided story.
DuBOIS RN
Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891
[No Abstract] [Full Text] [Related]
4. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
5. New paradigms for cancer prevention.
DuBois RN
Carcinogenesis; 2001 May; 22(5):691-2. PubMed ID: 11323385
[No Abstract] [Full Text] [Related]
6. Role of cyclooxygenase inhibitors for the prevention of colorectal cancer.
Stack E; DuBois RN
Gastroenterol Clin North Am; 2001 Dec; 30(4):1001-10. PubMed ID: 11764529
[TBL] [Abstract][Full Text] [Related]
7. [New anti-inflammatory analgetics--are they needed?].
Paakkari I
Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
[No Abstract] [Full Text] [Related]
8. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
9. Growth regulation of Gardner's syndrome colorectal cancer cells by NSAIDs.
Hughes-Fulford M; Boman B
Adv Exp Med Biol; 1997; 407():433-41. PubMed ID: 9321987
[No Abstract] [Full Text] [Related]
10. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
11. COX-1, COX-2: so what?
Emery P
Scand J Rheumatol; 1999; 28(1):6-9. PubMed ID: 10092158
[TBL] [Abstract][Full Text] [Related]
12. [Cyclooxygenases, structure, biological functions and the role in inflammation processes].
Kotyla PJ; Sliwińska-Kotyla B; Kucharz EJ
Pol Arch Med Wewn; 2001 Oct; 106(4):963-6. PubMed ID: 11993417
[No Abstract] [Full Text] [Related]
13. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Masmoudi A; Chevalier TL; Sabatier L; Soria JC
Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs to prevent colorectal cancer: a question of sensitivity.
Elder DJ; Paraskeva C
Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
[No Abstract] [Full Text] [Related]
15. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
Feldman M; McMahon AT
Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
[No Abstract] [Full Text] [Related]
16. COX-2 inhibitors and breast cancer.
Singh Ranger G; Mokbel K
ANZ J Surg; 2003 Aug; 73(8):565-6. PubMed ID: 12887516
[No Abstract] [Full Text] [Related]
17. Cyclooxygenase-2 and colorectal cancer.
DuBois RN
Prog Exp Tumor Res; 2003; 37():124-37. PubMed ID: 12795052
[No Abstract] [Full Text] [Related]
18. Cyclooxygenase-2 inhibitors in postoperative pain management: current evidence and future directions.
Gilron I; Milne B; Hong M
Anesthesiology; 2003 Nov; 99(5):1198-208. PubMed ID: 14576559
[No Abstract] [Full Text] [Related]
19. COX-2 inhibitors: cancer trials test new uses for pain drug.
Michalowski J
J Natl Cancer Inst; 2002 Feb; 94(4):248-9. PubMed ID: 11854385
[No Abstract] [Full Text] [Related]
20. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
